Daclatasvir Dihydrochloride and Sandostatin LAR Depot injection
Determining the interaction of Daclatasvir Dihydrochloride and Sandostatin LAR Depot injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclatasvir
Brand name: Daklinza
Synonyms: Daclatasvir
Generic Name: octreotide
Brand name: Sandostatin, Sandostatin LAR Depot
Synonyms: Sandostatin LAR Depot (injection)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclatasvir Dihydrochloride-Sani-Supp
- Daclatasvir Dihydrochloride-Sani-Supp rectal
- Daclatasvir Dihydrochloride-Sansert
- Daclatasvir Dihydrochloride-Santyl
- Daclatasvir Dihydrochloride-Saphris
- Daclatasvir Dihydrochloride-Sapropterin
- Sandostatin LAR Depot injection-Daclizumab
- Sandostatin LAR Depot injection-Daclizumab Subcutaneous
- Sandostatin LAR Depot injection-Dacogen
- Sandostatin LAR Depot injection-Dacomitinib
- Sandostatin LAR Depot injection-Dactinomycin
- Sandostatin LAR Depot injection-Dactinomycin Injection